Clinical Trials Browser

Phase 1/2 × Genital Diseases, Male × darolutamide × Clear all

Genital Diseases, Male, Prostatic Diseases, Prostatic Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant